inner page
|
FOCUS AREAS FOR THE STATE GOVERNMENT
By 2004 Department of Industries will bring the industrial development of Jharkhand at par with leading industrially developed states of the country. We intend to meet our objectives Byoptimal utilization of
By promoting economic activities to ensure maximum capital investment in the state. By identifying thrust areas and thrust zones to prioritize the sector. By developing state of the art technology and infrastructure for planned and accelerated industrial development. By encouraging and involving private sector participation By Promoting export of items where Jharkhand holds advantage over other states. By Simplification of procedures and time bound disposal of matters. Identification of Thrust Areas The State of Jharkhand is blessed with huge natural resources such as minerals, forests, water resources, energy sources, fertile land, etc. which can place the State amongst one of the top most prosperous and developed states of the country. Besides, the State is also gifted with relatively moderate climate, good rainfall, good rail and road communication, technical educational facilities, research laboratories, management institutes, etc. With a view to inculcate rapid growth in industrial sector, such industries which aim to utilities natural resources available in Jharkhand and which can generate employment for local inhabitants are being classified as thrust area. It is also intended to give boost to those industries, which propose to add value to the minerals, forest produce and agro based products available in the state. Important criteria for determining suitability of thrust industries for accelerated development in the states are:
The following industries have been identified as thrust areas for focused industrial development in the State:
|
MEDICINAL PLANS
The World health organisation (WHO) estimated that 80 percent of the population of developing countries relies on traditional medicines, mostly plant drugs, for their primary health care needs. It is understood that modern pharmacopoeia still contains at least 25 percent drugs derived from plants and many others which are synthetic analogues built on prototype compounds isolated from plants. Demand for medicinal plant is on the rise both in the developed and developing countries on account of the growing awareness of natural products being narcotic-free with practically no side-effects.
INDUSTRIES IN INDA According to an all India ethno biological survey carried out by the Ministry of Environment and Forests, Government of India, there are over 8000 species of medicinal plants grown in the country. There are estimated to be around 25,000 effective plant based formulation used in folk medicine and used in rural communities all over India and about 10,000 designed formulations are available in the indigenous medical texts. About 70 percent of India's medicinal plants are found in the tropical forests, spread across the Western and Eastern Ghats, theVindhyas, Chota Nagpur plateau, the Aravalis and Himalayan Ranges. The remaining 30 percent of the plants which are found in the temperate and alpine areas and at higher altitudes, are species of high medicinal value. One-third of the medicinal plants are trees, an equal portion of them shrubs and the remaining one-third consists of herbs, grasses and climbers. Indian system of medicine derives most of its formulations from plants and plant extracts that exist in the forest. Over 1.5 million practitioners of Indian system of medicine in the oral and codified streams use medicinal plants in preventive, promotive and curative applications. There are estimated to be over 7,800 manufacturing units in India, with the capacity to produce herbal extracts and drugs from crude botanicals. Annexure I provides data on annual production of crude herbal drugs in the country. It is understood that over 800 species are being used by the Indian industry, out of which only 20 species of plants are under commercial cultivation. More than 90 percent of the medicinal plants used in the industry are collected from the forests under wild growth. Over 70 percent of the plant collections result in destructive harvesting because of the use of parts like roots, bark, wood, stem and the whole plant in case of herbs (List of medicinal plants in short supply appears at Annexure II). Both global and national data on production and trade of medicinal plants are scanty. However, EXIM Bank in its occasional paper "Indian Medicinal Plants: A Sector Study" has estimated global trade in medicinal plants, at around $ 60 billion per year with an annual average growth of 7 percent. Trade within the country is rather complicated as it involves village markets, primary wholesale markets, secondary wholesale markets and terminal markets. Besides, trade in medicinal plants at all levels in India is marked by secrecy and opacity in working. Current practices of harvesting besides being unsustainable add to the confusion in identifying plant materials, where the origin of a particular drug is assigned to more than one plant, often with different characters, not compatible to one another. There are also cases where the identity of plant source is doubtful or unknown leading to adulteration and other undesirable practices. According to industry sources, India's annual herbal drug production is expected to reach Rs. 4000 crores by the end of 2002. medicinal Plants, which are traded in significant quantities in India include Amla, Aswahagandha, Neem, Sonamukhi, Kumari, Satavari, Shankhapushpi, Ashoka, Bael, Brahmi, Chandan, Giloe and Devdar. |
